United to change the trajectory of lung cancer
At Johnson & Johnson, we collaborate across our Pharmaceutical and MedTech teams and with strategic partners to unleash the full potential of lung cancer science to help change the trajectory of this complex disease.
“Our goal is to prevent lung cancer from happening in the first place”
Artificial intelligence-enabled mobile screening units. Nasal swab genomic tests. Diagnostics that pair the right treatment with the right patient. For Healthy Lung Month, Johnson & Johnson researchers share the progress that’s being made to thwart the #1 cancer killer.
How data science is ushering in a new era of modern medicine
Algorithms, artificial intelligence, machine learning and other technologies are transforming the way physicians identify, treat and manage diseases. Here’s how Johnson & Johnson is putting the latest tools to work.
Lung cancer requires a multidisciplinary approach
Interventional Oncology
Learn more about the work this research & development team is doing to develop best-in-class therapies delivered directly into tumors via minimally invasive procedures.
